Cinacalcet Tablet
Product Images NDC 71335-2763

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 71335-2763). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 01)

Chemical structure of cinacalcet hydrochloride, showing the molecular arrangement including trifluoromethyl, aromatic rings, and amine groups associated with the active ingredient cinacalcet.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 02)

A line graph comparing PTH levels (pg/mL) over 26 weeks between placebo and Cinacalcet tablets. The x-axis represents weeks from 0 to 26, and the y-axis shows PTH levels from 0 to 1000 pg/mL. Cinacalcet tablets (red line) show a marked decrease in PTH levels over time, while placebo (black dashed line) shows relatively stable or slightly increasing PTH levels.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 03)

A line graph comparing Ca x P (mg/dL) levels over 26 weeks between Cinacalcet tablets and placebo groups. The graph shows the Cinacalcet group with a decreasing trend starting around 60 mg/dL, leveling near 50 mg/dL, while the placebo group remains around 60 mg/dL. Error bars indicate variability at each time point.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 04)

A line graph depicting calcium levels (mg/dL) over time in weeks during titration and maintenance phases in parathyroid carcinoma patients (n=29). The x-axis represents weeks from baseline through week 80, and the y-axis measures calcium concentration from 8 to 16 mg/dL, with error bars indicating variability.*

FDA Label Image

Image (00722e4a 7103 49ef 8cfd 6a14b0088f0e 05)

A line chart depicting serum calcium levels (mg/dL) over a span of 80 weeks during titration and maintenance phases in a study. The x-axis represents weeks, while the y-axis shows calcium levels, with error bars indicating variability. Below the x-axis, percentages of patients with intractable secondary hyperparathyroidism (pHPT) are noted at various time points.*

FDA Label Image

Label (Lbl713352763)

Label for Cinacalcet Tablets 90 mg, oral dosage form. The package contains 30 tablets, relabeled by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Cipla Ltd. The label includes storage instructions, dosage note to scan package insert QR code, and barcodes. The strength is specified as 90 mg per tablet, equivalent to Cinacalcet Hydrochloride 99 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.